AstraZeneca is transforming Boston's AI ecosystem by fostering collaboration and integrating data across biotech, academia, and healthcare, moving away from traditional siloed research methods. This approach emphasizes data integration over accumulation, treats drug discovery as a software problem, and highlights the importance of culture in driving innovation and scalability for AI-driven organizations.
Read the full article at AI Accelerator Institute | Future of Artificial Intelligence
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





